James S Scibetta's Net Worth

$14.9 Million

Estimate Recalculated Apr 10, 2025 08:46PM EST

Who is James S Scibetta

James S Scibetta has an estimated net worth of $14.9 Million. This is based on reported shares across multiple companies, which include Matinas BioPharma Holdings, Inc., Pacira Pharmaceuticals, Inc., NEPHROS INC, Aquestive Therapeutics, Inc., and BIOENVISION INC.

SEC CIK

James S Scibetta's CIK is 0001383242

Past Insider Trading and Trends

2019 was James S Scibetta's most active year for acquiring shares with 10 total transactions. James S Scibetta's most active month to acquire stocks was the month of May. 2014 was James S Scibetta's most active year for disposing of shares, totalling 14 transactions. James S Scibetta's most active month to dispose stocks was the month of October. 2015 saw James S Scibetta paying a total of $331,000.00 for 60,000 shares, this is the most they've acquired in one year. In 2016 James S Scibetta cashed out on 90,000 shares for a total of $1,860,250.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Matinas BioPharma Holdings, Inc.

Investor
Updated Nov 03, 2023
Form 4
437.24K
Nov 03, 2023
437.24K
Grant
Nov 01
Form 4
142.66K
Nov 16, 2022
142.66K
Grant
Nov 14
Form 4
90.88K
Nov 02, 2021
90.88K
Grant
Nov 01
Form 4
4.63%
28.79K
Jun 24, 2021
649.96K
Options
Jun 19
Form 4
122.61K
Nov 10, 2020
122.61K
Grant
Nov 02
Form 4
0.58%
3.60K
Jun 24, 2020
621.16K
Acquisition
Jun 23
Form 4
1.36%
8.26K
Jan 03, 2020
617.56K
Grant
Dec 31
Form 4
107.42K
Nov 05, 2019
107.42K
Grant
Nov 01
Form 4
5.57%
32.14K
Oct 02, 2019
609.30K
Acquisition
Jun 21 - Sep 30
Form 4
3.94%
21.88K
Jul 02, 2019
577.16K
Grant
Jun 30
Form 4
3.20%
17.20K
Apr 03, 2019
555.28K
Grant
Mar 31
Form 4
6.22%
31.51K
Jan 04, 2019
538.08K
Grant
Dec 31
Form 4
256.60K
Nov 05, 2018
256.60K
Grant
Nov 01
Form 4
4.19%
20.38K
Oct 03, 2018
506.57K
Grant
Oct 01
Form 4
9.75%
43.20K
Jul 11, 2018
486.18K
Grant
Jun 29
Form 4
12.00
$1,000.00
$12.00K
Jun 22, 2018
12.00
Purchase
Jun 21
Form 4
5.90%
24.67K
Apr 02, 2018
442.98K
Grant
Mar 30
Form 4
1.21%
5.00K
$1.29
$6.45K
Sep 07, 2017
418.31K
Purchase
Sep 07
Form 3
Mar 01, 2017
413.31K
Showing 19 results

Pacira Pharmaceuticals, Inc.

President
Updated Jun 07, 2017
Form 4
-7.26%
-1.97K
$43.32
-$85.17K
Jun 07, 2017
25.12K
Sale
Jun 05
Form 4
-32.08%
-20.00K
$28.35
-$914.20K
May 17, 2017
42.34K
Sale
ScheduledMay 15
Form 4
-24.29%
-20.00K
$21.78
-$670.11K
Jan 19, 2017
62.34K
Sale
ScheduledJan 17
Form 4
20.00K
Dec 09, 2016
20.00K
Grant
Dec 07
Form 4
-40.44%
-20.00K
$19.06
-$697.80K
Nov 17, 2016
29.46K
Sale
ScheduledNov 15
Form 4
-33.58%
-25.00K
$23.41
-$1.09M
Aug 17, 2016
49.46K
Sale
ScheduledAug 15
Form 4
464.11%
48.75K
Jun 17, 2016
59.25K
Grant
Jun 15
Form 4
40.00K
Nov 05, 2015
40.00K
Grant
Nov 03
Form 4
90.84%
5.00K
$61.37
$306.85K
Sep 14, 2015
10.50K
Purchase
Sep 11
Form 4
-25.65%
-15.00K
$56.42
-$1.64M
Feb 09, 2015
43.48K
Sale
ScheduledFeb 06
Form 4
-20.48%
-15.00K
$44.40
-$1.28M
Nov 12, 2014
58.25K
Sale
ScheduledNov 07
Form 4
-15.40%
-15.00K
$50.62
-$1.47M
Aug 11, 2014
82.37K
Sale
ScheduledAug 08
Form 4
70.00K
Jun 05, 2014
70.00K
Grant
Jun 03
Form 4
-39.49%
-15.00K
$38.33
-$1.10M
May 09, 2014
22.99K
Sale
ScheduledMay 08
Form 4
-20.84%
-10.00K
$28.58
-$539.40K
Jan 02, 2014
37.99K
Sale
ScheduledDec 30
Form 4
-17.24%
-10.00K
$24.18
-$451.30K
Oct 02, 2013
47.99K
Sale
ScheduledSep 30
Form 4
-14.71%
-10.00K
$14.83
-$264.36K
Jul 02, 2013
57.99K
Sale
ScheduledJun 28
Form 4
-12.82%
-10.00K
$15.05
-$268.80K
Apr 01, 2013
67.99K
Sale
ScheduledMar 28
Form 4
150.00K
Jun 07, 2012
150.00K
Grant
Jun 05
Form 4
5.00K
$7.04
$35.20K
Feb 16, 2011
5.00K
Purchase
Feb 15
Form 3
Feb 02, 2011
Showing 21 results

NEPHROS INC

Investor
Updated Jan 07, 2014
Form 4
60.44K
Jan 07, 2014
60.44K
Grant
Dec 31
Form 4
23.20%
12.08K
Aug 22, 2013
64.13K
Grant
Aug 20
Form 4
64.56K
Jun 11, 2013
64.56K
Grant
May 23
Form 4
12.50K
Mar 20, 2012
12.50K
Grant
Feb 16
Form 4
60.00K
Mar 28, 2011
63.13K
Grant
Mar 24
Form 4
22.50K
Jan 26, 2010
62.50K
Grant
Jan 08
Form 4
20.00K
Aug 20, 2009
40.00K
Grant
Aug 17
Form 4
20.00K
Dec 04, 2007
20.00K
Grant
Nov 30
Form 3
Nov 26, 2007
Showing 9 results

Aquestive Therapeutics, Inc.

Investor
Updated Jun 17, 2021
Form 4
20.00K
Jun 17, 2021
51.64K
Grant
Jun 15
Form 4
14.00K
Jun 18, 2020
45.64K
Grant
Jun 16
Form 4
265.13%
22.97K
$3.79
$86.98K
Aug 22, 2019
31.64K
Purchase
Aug 19 - Aug 21
Form 4
13.35K
Jun 17, 2019
22.01K
Grant
Jun 13
Form 4
26.70K
Jul 26, 2018
26.70K
Grant
Jul 24
Form 3
Jul 24, 2018
8.66K
Showing 6 results

BIOENVISION INC

Chief Financial Officer
Updated Dec 11, 2006
Form 3
Dec 11, 2006
Showing 1 results